9.93 USD
▲+0.20+2.00%
盘后 9.88 -0.48%
2026-11-19
市值
$1.04B
市盈率
—
EPS
-3.21
股息率
—
52 周区间
9.60 – 17.50
成交量
909.56K
Beta
0.60
目标价
18.00
52W 低 9.6052W 高 17.50
价格走势
公司简介
Freenome, Inc., a biotechnology company, develops blood-based screening tests to detect cancer in the United States. The company offers an early cancer detection platform that integrates multiomics, artificial intelligence, and machine learning to uncover complex biological signals associated with cancer. It develops SimpleScreen™ CRC, a blood-based test, including a test for colorectal cancer screening, as well as tests for multi-cancer and multi-disease detection, such as lung, breast, cervical, liver, pancreatic, and esophageal cancers. The ...